Yongyi Cheng

Fisetin, a Dietary Flavonoid, Induces Cell Cycle Arrest and Apoptosis through Activation of p53 and Inhibition of NF‐Kappa B Pathways in Bladder Cancer Cells

Jing Li, Yongyi Cheng, Weixing Qu et al. · Basic & Clinical Pharmacology & Toxicology · 2010 · 122 citations

The Inhibitory Effect of Intravesical Fisetin against Bladder Cancer by Induction of p53 and Down‐Regulation of <scp>NF</scp>‐kappa B Pathways in a Rat Bladder Carcinogenesis Model

Jing Li, Weixing Qu, Yongyi Cheng et al. · Basic & Clinical Pharmacology & Toxicology · 2014 · 53 citations

Chemoprevention Strategy, Intravesical Chemotherapy, Pharmacotherapy +18

SPOP promotes tumor progression via activation of β-catenin/TCF4 complex in clear cell renal cell carcinoma

Wencai Zhao, Jiancheng Zhou, Zhuo Deng et al. · International Journal of Oncology · 2016 · 49 citations · Full text

Renal Pathology, Tumor Progression, Pathology +21

NF-κB signaling plays irreplaceable roles in cisplatin-induced bladder cancer chemoresistance and tumor progression

Yi Sun, Zhenfeng Guan, Liang Liang et al. · International Journal of Oncology · 2015 · 41 citations · Full text

Urology, Bca Chemotherapy, Genitourinary Cancer +13

HIF-1α/MDR1 pathway confers chemoresistance to cisplatin in bladder cancer

Yi Sun, Zhenfeng Guan, Liang Liang et al. · Oncology Reports · 2015 · 40 citations · Full text